Skip to content

Clinical features and treatment of atrophic papulosis:a retrospective observational study

Clinical features and treatment of atrophic papulosis (Degos disease):a retrospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121884
Enrollment
Unknown
Registered
2026-04-07
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degos disease

Interventions

research group:None

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed with atrophic papulosis (Degos disease); 2. No age limit, both men and women are eligible. 3.The medical record is complete and should at least include the following core information: demographic characteristics, age of onset, disease course, clinical symptoms (characteristics of skin lesions, systemic involvement manifestations), laboratory tests (erythrocyte sedimentation rate, C-reactive protein, autoantibodies, etc.), imaging/pathological examination results, treatment plan, and follow-up records.

Exclusion criteria

Exclusion criteria: 1.The diagnosis is not clear. It is only clinically suspected to be Degos disease. There are no characteristic skin manifestations, and there is a lack of support from pathological, imaging or laboratory tests, making it impossible to make a definite diagnosis. 2.The coexistence of severe cardiovascular and cerebrovascular diseases, malignant tumors, and severe infections may interfere with the clinical assessment and prognosis judgment of Degos disease. 3.There were no clear follow-up records, or the patients withdrew voluntarily or were lost to follow-up during the follow-up period, making it impossible to obtain information on therapeutic effects and prognosis.

Design outcomes

Primary

MeasureTime frame
Clinical manifestations;

Countries

China

Contacts

Public ContactTao Wang

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical

wangtaopumch@126.com+86 10 6915 1502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026